Connexin43 Suppresses Lung Cancer Stem Cells

Area of Science:

• Cell Biology
• Oncology
• Molecular Medicine

Background:

• Gap junctions and connexins are implicated in cancer development and drug resistance.
• Their specific role in lung cancer stem cells (CSCs) remains less understood.
• Connexin43 (Cx43) is a key protein in human lung epithelial gap junctions.

Purpose of the Study:

• To investigate the role of Connexin43 (Cx43) in human lung cancer stem cells (CSCs).
• To evaluate the impact of ectopic Cx43 expression on lung adenocarcinoma cell characteristics and CSC abundance.

Main Methods:

• Ectopic expression of Cx43 in NCI-H125 lung adenocarcinoma cells.
• Analysis of phenotypic changes, including morphology, proliferation, invasion, and colony formation.
• Quantification of CSC markers, such as aldehyde dehydrogenase (ALDH) positivity and tumorsphere formation.
• Assessment of cisplatin sensitivity in Cx43-expressing cells.

Main Results:

• Ectopic Cx43 expression restored functional gap junctions and epithelial morphology.
• Cx43 significantly reduced proliferation, invasion, colony and tumorsphere formation, and CSC marker expression.
• Cx43 expression increased sensitivity to cisplatin chemotherapy.
• Endogenous Cx43 levels were lower in CSC populations (tumorspheres, ALDH-positive cells) of other lung cancer cell lines.

Conclusions:

• Connexin43 (Cx43) can reverse key neoplastic characteristics in lung cancer cells.
• Cx43 expression effectively reduces the abundance of lung cancer stem cells (CSCs).
• Cx43 represents a potential therapeutic target for improving lung cancer treatment outcomes.